Alexis V.
- Country
- France
- Department
- Radiotherapy
Research Overview
- Efficacy of Zoledronic Acid or Denosumab with Stereotactic Radiotherapy in Inoperable Vertebral Bone Metastases: A Randomized Controlled Study
- Evaluation of Darolutamide Combined with Stereotactic Body Radiation Therapy in Castration-Resistant Prostate Cancer with Oligometastases Detected by Functional Imaging
- Evaluation of Darolutamide and Stereotactic Dose-Escalated Radiotherapy in High-Risk Localized Prostate Cancer: A Phase III Randomized Trial
Data & Insights
Has run more than one trial at 28 of 82 partner sites.
Specializations
Prostate Cancer Management
The investigator specializes in treating high-risk prostate adenocarcinoma and explores advanced therapeutic approaches for patients experiencing biochemical progression after radical prostatectomy.
- Post-surgical Treatment Optimization
- Salvage Radiotherapy Applications
- Hormone Therapy Integration
Particular focus is placed on combining novel androgen receptor inhibitors with established treatment modalities.
Advanced Imaging and Treatment
Expertise in utilizing functional imaging techniques for detecting and treating localized prostate cancer with high-risk features, incorporating next-generation diagnostic tools such as PSMA PET/CT.
- Stereotactic Radiotherapy
- Targeted Pelvic Treatment
- Metastasis Prevention Strategies
Integration of modern imaging with precise radiation delivery methods for optimal treatment outcomes.
Metastatic Disease Treatment
Focus on managing vertebral bone metastases through combined therapeutic approaches, including evaluation of bone-targeted agents with stereotactic radiotherapy.
- Bone Metastasis Management
- Cost-Utility Analysis
- Multi-Modal Treatment Strategies
Specialized attention to inoperable metastatic conditions requiring advanced radiotherapy solutions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.